Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001400253-26-000041

Chief Financial Officer disposed of 138 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Carter Robert Ross · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-11-17 Other disposition : show line 1 in the form −138 $3.40 $469 414,663 D
Loading xslF345X06/ownership.xml…